Glucose-dependent Insulinotropic Polypeptide Receptor Agonist drugs
2 medications in the FDA established pharmacologic class “Glucose-dependent Insulinotropic Polypeptide Receptor Agonist”.
2 medications in the FDA established pharmacologic class “Glucose-dependent Insulinotropic Polypeptide Receptor Agonist”.